Up to 50% of women have reported that they struggle with sleep issues in midlife, while CVD stands as the main cause of death in women.
Poor sleep in midlife can be associated with a higher risk of cardiovascular disease (CVD) among women, according to a study recently published in the American Heart Association’s Circulation journal.
Up to 50% of women have reported that they struggle with sleep issues in midlife, while CVD stands as the main cause of death in women.
Midlife, typically between ages 40 to 65, is a crucial time that involves both heart health and sleep, especially during menopause for women. During menopause, women often experience heart risks sooner.
Researchers of the study examined whether changes in sleep patterns during midlife could be linked to heart-related issues later in life as the association between long-term sleep troubles in midlife and heart disease risk in women is still unclear.
In a prospective cohort, participants who were part of the SWAN study (Study of Women’s Health Across the Nation), had their sleep monitored up to 16 times over 22 years.
Beginning in 1996 and on, up to 2,964 participants aged 42 to 52 from seven U.S. sites participated in annual examinations.
Women were either in their premenopausal or early perimenopausal stage, not using hormone therapy and free of CVD.
In over 16 visits, women in the SWAN study answered questionnaires about insomnia symptoms, sleep duration, vasomotor symptoms and depression.
Researchers used group-based trajectory modeling to map sleep patterns (insomnia and sleep duration).
Cox proportional hazards models were then used to test how these sleep trajectories related to CVD, considering factors like site, age, race, education and CVD risk factors.
After over two decades of review, researchers identified four patterns of insomnia symptoms among women: low symptoms (39%), moderate symptoms decreasing (19%), low symptoms increasing (20%) and persistent high symptoms (23%).
Women with consistently high insomnia had a 1.71 times higher risk of CVD compared to those with low symptoms.
Sleep duration revealed three patterns: persistently short (~5 hours, 15%), moderate (~6 hours, 55%), and moderate to long (~8 hours, 30%).
Women with persistent short sleep had a 1.51 times higher CVD risk.
Those with both persistent high insomnia and short sleep faced a 1.75 times higher CVD risk. Adjustments for other factors like vasomotor symptoms, snoring, or depression still showed a connection between insomnia and CVD.
Among many strengths, one major strength of this study lies in tracking sleep patterns across 16 assessments over two decades in midlife, a comprehensive approach.
Unlike previous studies where sleep's link to heart risk was studied at one point in time, this one spans the entire midlife, providing crucial insights into chronic poor sleep's connection to cardiovascular disease risk, especially in older women.
This study also has some limitations including the group with moderate to long sleep (about 7.70 hours) may limit conclusions about longer sleep.
In addition, researchers considered insomnia and sleep duration in this study, not other sleep aspects like timing and regularity.
It’s encouraged in future studies to explore both time and regularity.
This two-decade study on midlife women revealed that having ongoing trouble sleeping, especially when combined with consistently short sleep, increased the risk of heart disease by 70% to 75%.
These results highlight the need to include sleep patterns in assessing heart disease risk for women and emphasize how long-term poor sleep can impact heart health.
The proposed rule for the fiscal year (FY) 2025 Inpatient Prospective Payment System and Long-Term Care Hospital Prospective Payment System introduces strategies to improve the well-being of Medicare beneficiaries, including efforts to tackle social determinants of health, create more robust emergency readiness and enhance maternal healthcare.
Read More
The IRA’s Impact on Women in Medicare
April 2nd 2024In 2025, the out-of-pocket cap and other Part D related provisions in the Inflation Reduction Act are projected to save women in Medicare an average of 28% in out-of-pocket costs, according to a new analysis from the Office of the Assistant Secretary for Planning and Evaluation.
Read More
With aging populations, osteoporosis rates are set to increase, and researchers are looking for the next innovative drug to help prevent or manage the bone disease as there is currently no drug that completely does so effectively, according to a recent study published in Advanced Science.
Read More
The Rise in ‘Menopause’ and ‘Mommy Makeovers’: Navigating Aging and Hormonal Shifts with Aesthetics
March 13th 2024As women age, hormonal shifts during menopause often bring visible changes in their physical appearance. Cynthia Elliott, M.D., owner and primary practitioner at Skinspirations, shed light on the concept of "menopause makeovers" and how medical aesthetic procedures can address these changes toward women.
Read More